aJames Q. Del Rosso, DO, FAOCD, FAAD; bEmil A. Tanghetti, MD; cHilary E. Baldwin, MD; dDavid A. Rodriguez, MD; eIlia L. Ferrusi, PhD aJDR Dermatology Research/Thomas Dermatology, Las Vegas, Nevada
aAndrew F. Alexis, MD, MPH; bFran Cook-Bolden, MD; cTina Lin, PharmD aDepartment of Dermatology, Mount Sinai St. Luke’s and Mount Sinai West, New York, New York bSkin Specialty Dermatology and
Roger I. Ceilley, MD Dermatology PC, West Des Moines, Iowa Disclosure: The author acknowledges the editorial assistance of Dr. Carl S. Hornfeldt, Apothekon, Inc., with funding provided by Ferndale Healthcare.
Shivani B. Kaushik, MD; Andrew F. Alexis, MD, MPH Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York Disclosure: The authors report no relevant conflicts
by Philip R. Cohen, MD Dear Editor: I read with interest the recent report by Snyder et al[1] describing melasma associated with the application of a topical estrogen cream. The